Search

Your search keyword '"Rudin, C"' showing total 95 results

Search Constraints

Start Over You searched for: Author "Rudin, C" Remove constraint Author: "Rudin, C" Topic medicine Remove constraint Topic: medicine
95 results on '"Rudin, C"'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

3. Children living with HIV in Europe: do migrants have worse treatment outcomes?

4. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

5. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

6. Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

7. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study

8. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

9. Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population

10. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants

11. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

12. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption

13. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

14. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

15. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

16. Mögliche Aggravation einer Purpura Schönlein-Henoch durch Isotretinoin

17. Combination antiretroviral therapy and duration of pregnancy

18. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery

19. Increases in Condomless Sex in the Swiss HIV Cohort Study

20. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

21. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

22. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

23. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013

24. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

25. Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study

26. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

27. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation

28. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

29. The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type 1 — A Meta-Analysis of 15 Prospective Cohort Studies

30. The immunological and virological consequences of planned treatment interruptions in children with HIV infection

31. Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients

32. Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-< 36 months

33. Non Calcific Vasculopathy in the Basal Ganglia

34. Wie häufig kann die klinische Diagnose des Dreitagefiebers mit der HHV-6-Serologie bestätigt werden?

35. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

36. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

37. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

38. Infants with CMV and HIV-1

39. Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study

40. Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy

41. The influence of human genetic variation on Epstein-Barr virus sequence diversity

42. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

43. Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART

44. Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis

45. Repeated syphilis episodes in HIV-infected men who have sex with men: a multicenter prospective cohort study on risk factors and the potential role of syphilis immunity

46. Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study

47. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

48. Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort

49. Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV

50. Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART

Catalog

Books, media, physical & digital resources